Nutex Health Inc. Common Stock (NUTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NUTX trades at $121.54 with a market cap of $858.10M and a P/E ratio of 10.88. NUTX moved -3.70% today. Year to date, NUTX is -27.50%; over the trailing twelve months it is -31.41%. Its 52-week range spans $17.66 to $193.07. Analyst consensus is buy with an average price target of $237.50. Rallies surfaces NUTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own NUTX include Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nutex Health Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $121.54 |
| Market Cap | $858.10M |
| P/E Ratio | 10.88 |
| EPS | $11.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $193.07 |
| 52-Week Low | $17.66 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $875.26M |
| Net Income | $180.36M |
| Gross Margin | 50.76% |
2 analysts cover NUTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $237.50.